Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Hormones and the Endocrine System > Orforglipron for Sale > Orforglipron | Oral GLP-1 Agonist | Small-Molecule | 99% Purity | CAS 2212020-52-3 | White Powder | Diabetes&Weight Loss
Orforglipron | Oral GLP-1 Agonist | Small-Molecule | 99% Purity | CAS 2212020-52-3 | White Powder | Diabetes&Weight Loss buy - large image1
Orforglipron | Oral GLP-1 Agonist | Small-Molecule | 99% Purity | CAS 2212020-52-3 | White Powder | Diabetes&Weight Loss buy - image1

Orforglipron | Oral GLP-1 Agonist | Small-Molecule | 99% Purity | CAS 2212020-52-3 | White Powder | Diabetes&Weight Loss

GMP ISO FDA COA 25 Inquiries

Unit Price: Get Latest Price
CAS No.:

2212020-52-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Beijing

Packaging:

5g/10g/20g/50g/100g/500g/1000g

Price valid (until):

2026-05-10

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Tirzepatide,Semaglutide,Retatrutide,Liraglutide,Semax,Acetate

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


      Orforglipron – High-Purity GLP-1 Receptor Agonist (RUO)

    CAS: 2212020-52-3 | ≥99% Purity | White Powder

    Orforglipron is a next-generation oral GLP-1 receptor agonist designed for advanced metabolic research. It plays a key role in studies of glucose regulation, appetite control, and energy balance pathways, making it a highly valuable compound in diabetes and obesity-related research. 

    Compared with traditional peptide GLP-1 analogs, Orforglipron offers improved oral activity and strong receptor selectivity, supporting more flexible experimental design in metabolic studies.

    Widely used in research focusing on:
    • GLP-1 receptor signaling mechanisms
    • Blood glucose regulation pathways
    • Obesity and weight management models
    • Appetite and energy metabolism studies
    • Incretin-based drug discovery research

    Product Highlights:
    ✔ High Purity ≥99%
    ✔ Excellent Stability
    ✔ Consistent Batch Quality
    ✔ Scalable Production (100–200 kg)
    ✔ Suitable for R&D and laboratory use

    Orforglipron is a key reference compound in modern incretin research and is often studied alongside advanced metabolic agents to better understand multi-pathway glucose and weight regulation systems.

    ⚠ Research Use Only (RUO) 

    Contact Us

    Ms. Iris

    Tel/Whatsapp:+86 13002751028

    Email: Irisbian@transcoasia.com

    Specifications
    White powder
    Purity ≥ 99%
    Bacterial endotoxins: <10EU/mg


      Company IntroductionShop Orforglipron | Oral GLP-1 Agonist | Small-Molecule | 99% Purity | CAS 2212020-52-3 | White Powder | Diabetes&Weight Loss-Detailed Image 1 Shop Orforglipron | Oral GLP-1 Agonist | Small-Molecule | 99% Purity | CAS 2212020-52-3 | White Powder | Diabetes&Weight Loss-Detailed Image 2  


    Certificates

    Basic Info
    Product Name:

    Orforglipron

    Other Name:

    1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcy...;LY3502970;GLP-1 receptor agonist 1 USP/EP/BP;Orforglipron;Orforglipron(LY3502970);LY3502970 (Orforglipron);3-((1S,2S)-1-(5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one;OWL 833

    CAS No.:

    2212020-52-3

    Molecular Formula:

    C48H48F2N10O5

    InChIKeys:

    USUWIEBBBWHKNI-BBGRWQLENA-N

    Molecular Weight:

    882.97

    EC Number:

    278-636-5

    Color/Form:

    Off-white to light yellow

    Characteristics
    Density:

    1.50±0.1 g/cm3(Predicted)

    PKA:

    7.33±0.20(Predicted)

    Critical Temperature & Pressure:

    Store at -20°C

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Semaglutide,Retatrutide,Liraglutide,Semax,Acetate

    Location:

    Qingtie Plaza, No. 118 Changjiang West Road, Huangdao District

    Payment Terms:

    O/A,100% TT in advance

    Average lead Time:

    5

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    11-50

    Year of Establishment:

    2019

  • Inquiry History
    25 Inquiries
    Country Product Purchase Quantity Date Posted
    Bulgaria

    orforglipron

    1 KG Aug 27, 2025
    Austria

    Orforglipron

    1000 MT Jun 12, 2026
    Switzerland

    Orforglipron

    10 MG Apr 25, 2026
    United States

    Orforglipron

    20 G Apr 3, 2026
    United States

    Orforglipron

    10 G Mar 29, 2026
    United States

    oforglipron

    3 KG Jul 4, 2025
    Belgium

    Orforglipron

    1 G Jun 14, 2026
    Puerto Rico

    Orforglipron

    1 G Mar 2, 2026
    United States

    Orforglipron

    10 G Oct 24, 2025
    United States

    Orforglipron

    1 G Sep 30, 2025
    United States

    Orforglipron

    1 G Sep 26, 2025
    United States

    Orforglipron

    1 G Sep 26, 2025
    United States

    orforglipron

    1 MT Sep 20, 2025
    United States

    Orforglipron

    1 KG Apr 18, 2025
    Canada

    LY-3502970

    10 G Feb 26, 2026
    United States

    orforglipron

    10 G Apr 20, 2026
    United States

    Orforglipron

    10 G Apr 6, 2026
    United States

    orforglipron

    1 G Mar 24, 2026
    Germany

    Orforglipron

    2 G Mar 23, 2026
    Bangladesh

    Orforglipron

    500.00 KG Mar 9, 2026
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.